The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Podcasts
In this three-part webcast, Howard Mann, Vice President, Supply Chain Management at Cardiovascular Care Group discusses the basics and relationship
Podcasts
Learn about how the significant number of clinical alarms have a numbing effect on nursing staff, to the point that patient safety is in jeopardy.
On-Demand Educational Webinars
This session explains the benefits of implementing the UDI such as immediate device status updates through collaboration with manufacturers and…
On-Demand Educational Webinars
Outsourcing of hospital functions is a common and growing practice in the U.S. and comprises on average 25% of total non-labor spend in hospitals.…
Webcast
Lana Makhanik and Peter Fiorentino discuss discus why Beth Israel Deaconess Medical Center is breathing easier after they overhauled their inventor
Podcasts
Hear one provider’s ongoing process of UDI implementation, from deciphering acronyms and educating interdepartmental staff, to working with vendors